Company profile

Odin Medical

Medical Imaging & Radiology

Company profile

About Odin Medical

Odin Vision is an award-winning cloud AI endoscopy company founded by a team of eminent clinicians and artificial intelligence experts with the mission of creating the next generation of cloud AI-enabled applications for endoscopy. The company has been acquired by Olympus and operates as Odin Medical Ltd. Odin Vision believes that cloud and AI will create a new era of healthcare by supporting doctors to deliver higher-quality care leading to improved patient outcomes, better patient experiences, and increased value for healthcare providers. The company's flagship products include CADDIE, a cloud-based AI system for colonoscopy that provides automatic polyp detection, colonic landmark detection, and bowel preparation reporting, and CADU, a cloud-based AI system for gastroscopy. The technology was spun out of research conducted at University College London's Wellcome Trust and EPSRC Centre for Surgical Sciences, where the founding team pioneered the use of artificial intelligence in endoscopy. Odin Vision's systems are designed to integrate seamlessly into clinical workflows with user-friendly interfaces and foot pedal controls, and have been deployed in hospitals across Europe including the UK, Germany, and Czech Republic.

Company description Odin Medical official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Odin Medical?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Colon cancer screening
  • Colorectal polyps
  • Gastrointestinal conditions

Who it serves

  • Endoscopy Centers
  • Health Systems
  • Hospitals
  • National Screening Centers

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsCzech Republic · Europe · Germany · United Kingdom
Company sourceOfficial website

Company milestones

Platform expansion

Acquired by Olympus. Installation at Military University Hospital Prague (National Colon Cancer Screening centre) in October 2022. UCL study publication comparing CADDIE to clinician performance in November 2022.

Partnerships

Recorded partners

  • Olympus (acquired by)
  • Siemens Healthineers (former employer of leadership)
  • University College London

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

CADDIE

Cloud-based AI for colonoscopy polyp detection and characterization

Software · Cloud SaaSCompany source

CADU

Cloud-based AI for gastroscopy procedures

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

[Gene therapy and cancer].

Ugeskrift for laeger · Mar 25, 2002

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

CADDIE

K252586 · 510k · Sep 12, 2025

CADDIE

K240044 · 510k · Jul 24, 2024

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Polyp detection

Automatic detection during colonoscopy

Polyp characterization

AI-assisted polyp classification

Colonic landmark detection

Automatic identification of anatomical landmarks

Bowel preparation quality

Automated reporting over time

University College London

Comparative study of CADDIE AI system versus clinician performance

Study demonstrated CADDIE performance compared to clinicians

Ústřední vojenská nemocnice, Praha (Military University Hospital, Prague)

CADDIE installation at National Colon Cancer Screening centre

Successful deployment at national screening center

Princess Alexandra's Hospital Trust

Polyp characterization with AI assistance in colonoscopy

Simple and user-friendly integration into clinical workflow with foot pedal

Sana Klinikum, Berlin – Lichtenberg

AI-assisted polyp characterization and detection in colonoscopy

Quick and easy setup with seamless clinical workflow integration

Western General Hospital

AI polyp detection in colonoscopy

Best AI polyp detection so far (qualitative assessment)

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Patrick Brandao

CRO

Luke Sampson

COO

Monica Bello

Head of Finance

Laura Jones

Head of Clinical Affairs

LinkedIn

06 · Company updates

Updates from Odin Medical

Recent articles published on Odin Medical's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon